Tiny trial tests new injectable implant in just 2 volunteers
NCT ID NCT07151638
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early trial tested the safety of a new injectable medical device called Fractomer Biomatrix in just 2 healthy volunteers. The device is designed to support soft tissue, but the main goal was to see if it causes any side effects. Participants received a single injection under the skin, and the implant was later removed. The study is currently suspended, so results are very limited.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Fractomer Biomatrix (injectable, bioresorbable medical device)
- What this could lead to
- If safe, this could pave the way for a new injectable material to support soft tissue repair.
- What could go wrong
- This is a very early, tiny safety study (only 2 participants) that is currently suspended. It does not test effectiveness, and the implant is removed after monitoring.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOFT TISSUE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nucleus Network
Saint Paul, Minnesota, 55114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Custom gum-saving abutment may improve dental implant outcomes
- Could a blood clot replace gum surgery for dental implants?
- Could a simple shot replace IV antibiotics? new study explores
- Sheep membrane may help cover exposed bone faster
- Oxygen boost for dental implants: tiny trial tests faster healing
- New study aims to find best scan for Kids' tumors